Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes

Author:

Straat Maaike E12ORCID,Martinez-Tellez Borja12,van Eyk Huub J12,Bizino Maurice B13,van Veen Suzanne4,Vianello Eleonora4,Stienstra Rinke56,Ottenhoff Tom H M4,Lamb Hildo J3ORCID,Smit Johannes W A6,Jazet Ingrid M12,Rensen Patrick C N12ORCID,Boon Mariëtte R12

Affiliation:

1. Division of Endocrinology, Department of Medicine, Leiden University Medical Center , 2333 ZA Leiden , the Netherlands

2. Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center , 2333 ZA Leiden , the Netherlands

3. Department of Radiology, Leiden University Medical Center , 2333 ZA Leiden , the Netherlands

4. Department of Infectious Diseases, Leiden University Medical Center , 2333 ZA Leiden , the Netherlands

5. Nutrition, Metabolism and Genomics Group, Division of Human Nutrition and Health, Wageningen University , 6708 PB Wageningen , the Netherlands

6. Department of Medicine, Radboud University Medical Center , 6525 XZ Nijmegen , the Netherlands

Abstract

Abstract Context South Asian individuals are more prone to develop type 2 diabetes (T2D) coinciding with earlier complications than Europids. While inflammation plays a central role in the development and progression of T2D, this factor is still underexplored in South Asians. Objective This work aimed to study whether circulating messenger RNA (mRNA) transcripts of immune genes are different between South Asian compared with Europid patients with T2D. Methods A secondary analysis was conducted of 2 randomized controlled trials of Dutch South Asian (n = 45; age: 55 ± 10 years, body mass index [BMI]: 29 ± 4 kg/m2) and Dutch Europid (n = 44; age: 60 ± 7 years, BMI: 32 ± 4 kg/m2) patients with T2D. Main outcome measures included mRNA transcripts of 182 immune genes (microfluidic quantitative polymerase chain reaction; Fluidigm Inc) in fasted whole-blood, ingenuity pathway analyses (Qiagen). Results South Asians, compared to Europids, had higher mRNA levels of B-cell markers (CD19, CD79A, CD79B, CR2, CXCR5, IGHD, MS4A1, PAX5; all fold change > 1.3, false discovery rate [FDR] < 0.008) and interferon (IFN)-signaling genes (CD274, GBP1, GBP2, GBP5, FCGR1A/B/CP, IFI16, IFIT3, IFITM1, IFITM3, TAP1; all FC > 1.2, FDR < 0.05). In South Asians, the IFN signaling pathway was the top canonical pathway (z score 2.6; P < .001) and this was accompanied by higher plasma IFN-γ levels (FC = 1.5, FDR = 0.01). Notably, the ethnic difference in gene expression was larger for women (20/182 [11%]) than men (2/182 [1%]). Conclusion South Asian patients with T2D show a more activated IFN-signaling pathway compared to Europid patients with T2D, which is more pronounced in women than men. We speculate that a more activated IFN-signaling pathway may contribute to the more rapid progression of T2D in South Asian compared with Europid individuals.

Funder

Novo Nordisk A/S

Dutch Diabetes Foundation

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference48 articles.

1. Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management;Sattar;Lancet Diab Endocrinol,2015

2. Diabetes and associated complications in the South Asian population;Shah;Curr Cardiol Rep,2014

3. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians;McKeigue;Lancet,1991

4. Pathogenesis of type 2 diabetes in South Asians;Bakker;Eur J Endocrinol,2013

5. High prevalence of cardiovascular disease in South Asians: central role for brown adipose tissue?;Boon;Crit Rev Clin Lab Sci,2015

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3